ghk cu peptide injection or topical GHK-Cu Therapy: The Definitive Clinical Guide to Gene Modulation, Protocols, and Efficacy GHK-Cu Topical: Evidence, Safety &

Or at 5.0 mg/mL, a 1.25mg dose would be: (1.25 / 5.0) x 100 = 25 units

and Jordan Rathlev, executive vice president of development of Related Ross

There are no completed Phase 2 or Phase 3 clinical trials of 5-Amino-1MQ in human participants

Topical and Injectable GHK-Cu Routes Compared Topical GHK-Cu has published cosmetic, wound, and trial-context evidence, while injectable GHK-Cu lacks an FDA-approved dosing label and is specifically discussed by FDA in relation to compounded injectable safety concerns [2], [3], [7], [8]

Local Targeting for Injuries Injections can also be administered locally near the site of injury , concentrating the peptides effects